Avita Medical shares rise 2.62% intraday after highlighting largest real-world analysis of RECELL technology.

Avita Medical, Inc. rose 2.62% in intraday trading, with the company highlighting data presented by researchers at the British Burn Association Annual Meeting. The data demonstrated reduced length of hospital stay among burn patients treated with RECELL®, the company's patented technology that uses a small sample of a patient’s own skin to produce Spray-On Skin™ Cells.